secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0001193805-24-001079
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic extends Executive Chairman Dr. Duane Nash's term to Dec 2025 with salary increase
--------------------------------------------------------------------------------

- Term of Executive Chairman Duane Nash extended to December 31, 2025 via Addendum No. 6.
- Monthly base salary raised to $33,987 from $32,368, inclusive of board retainer.
- Addendum effective August 29, 2024; all other employment terms unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380524001079/0001193805-24-001079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380524001079/e663859_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-24-001079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer